Amundi Purchases 321,879 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Amundi increased its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 18.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 2,039,247 shares of the real estate investment trust’s stock after acquiring an additional 321,879 shares during the quarter. Amundi’s holdings in Omega Healthcare Investors were worth $77,145,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Daiwa Securities Group Inc. lifted its stake in Omega Healthcare Investors by 317.7% during the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock valued at $160,739,000 after acquiring an additional 3,003,845 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Omega Healthcare Investors by 328.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust’s stock valued at $67,642,000 after acquiring an additional 1,274,238 shares during the period. Raymond James Financial Inc. bought a new position in Omega Healthcare Investors during the 4th quarter valued at about $20,058,000. FMR LLC lifted its stake in Omega Healthcare Investors by 9.9% during the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock valued at $171,625,000 after acquiring an additional 380,626 shares during the period. Finally, Franklin Resources Inc. increased its position in shares of Omega Healthcare Investors by 441.4% during the 3rd quarter. Franklin Resources Inc. now owns 429,993 shares of the real estate investment trust’s stock valued at $17,177,000 after purchasing an additional 350,570 shares during the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Trading Down 2.5 %

Omega Healthcare Investors stock opened at $36.68 on Wednesday. The firm has a 50 day moving average of $37.09 and a 200 day moving average of $38.98. The firm has a market capitalization of $10.34 billion, a price-to-earnings ratio of 23.67, a P/E/G ratio of 1.09 and a beta of 1.00. Omega Healthcare Investors, Inc. has a 12-month low of $29.66 and a 12-month high of $44.42. The company has a current ratio of 7.07, a quick ratio of 7.07 and a debt-to-equity ratio of 1.02.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.33. Omega Healthcare Investors had a return on equity of 9.71% and a net margin of 38.65%. As a group, research analysts predict that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, February 18th. Shareholders of record on Monday, February 10th were paid a $0.67 dividend. The ex-dividend date was Monday, February 10th. This represents a $2.68 annualized dividend and a yield of 7.31%. Omega Healthcare Investors’s payout ratio is 172.90%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Mizuho upped their price target on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the company a “neutral” rating in a research report on Thursday, December 5th. BMO Capital Markets raised shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price target for the company in a research report on Monday, December 9th. JMP Securities reaffirmed a “market perform” rating on shares of Omega Healthcare Investors in a research report on Friday, February 7th. Finally, Wells Fargo & Company reduced their price target on shares of Omega Healthcare Investors from $43.00 to $41.00 and set an “overweight” rating for the company in a research report on Monday. Five investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Omega Healthcare Investors has a consensus rating of “Moderate Buy” and a consensus price target of $41.44.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.